Vofatamab Biosimilar (FGFR3 / CD333 Reference Antibody)
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb) . Vofatamab blocks activation of both the wildtype and genetically activated receptor. Vofatamab can be used in the research of metastatic urothelial carcinoma (mUC) .
Product Specifications
Target
Vofatamab Biosimilar (Anti-FGFR3 / CD333 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation; Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
B3000-02-PE 100 µL
BST1 (ADP-ribosyl Cyclase 2, Bone Marrow Stromal Antigen 1, BST-1, Cyclic ADP-ribose Hydrolase 2, cADPr Hydrolase 2, CD157) (PE)
Sign In for Pricing
View Details 